Expression of the Growth Hormone/Insulin-Like Growth Factor Axis during Balb/c Thymus Ontogeny and Effects of Growth Hormone upon ex vivo T Cell Differentiation (original) (raw)
Article navigation
Research Articles| January 18 2012
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
cLaboratory of Experimental Medicine and Endocrinology, Catholic University of Leuven, Leuven, Belgium
Search for other works by this author on:
bDepartment of Hematology, University of Liège, CHU-B23, Liège-Sart Tilman, and
Search for other works by this author on:
bDepartment of Hematology, University of Liège, CHU-B23, Liège-Sart Tilman, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
aCenter of Immunology, Institute of Pathology, and
Search for other works by this author on:
Neuroimmunomodulation (2012) 19 (3): 137–147.
Received:
January 19 2011
Published Online:
January 18 2012
Citation
Hamid Kermani, Lindsay Goffinet, Marie Mottet, Gwenaelle Bodart, Gabriel Morrhaye, Olivier Dardenne, Chantal Renard, Lut Overbergh, Frédéric Baron, Yves Beguin, Vincent Geenen, Henri J. Martens; Expression of the Growth Hormone/Insulin-Like Growth Factor Axis during Balb/c Thymus Ontogeny and Effects of Growth Hormone upon ex vivo T Cell Differentiation. _Neuroimmunomodulation 1 March 2012; 19 (3): 137–147. https://doi.org/10.1159/000328844
Download citation file:
Abstract
Aims: We address the question of the expression and the role of the growth hormone/insulin-like growth factor (GH/IGF) axis in the thymus. Methods: Using RT-qPCR, the expression profile of various components of the somatotrope GH/IGF axis was measured in different thymic cell types and during thymus embryogenesis in Balb/c mice. The effect of GH on T cell differentiation was explored via thymic organotypic culture. Results: Transcription of Gh, Igf1, Igf2 and their related receptors predominantly occurred in thymic epithelial cells (TEC), while a low level of Gh and Igf1r transcription was also evidenced in thymic T cells (thymocytes). Gh, Ghr, Ins2, Igf1, Igf2, and Igfr1 displayed distinct expression profiles depending on the developmental stage. The protein concentrations of IGF-1 and IGF-2 were in accordance with the profile of their gene expression. In fetal thymus organ cultures (FTOC) derived from Balb/c mice, treatment with exogenous GH resulted in a significant increase of double negative CD4–CD8– T cells and CD4+ T cells, together with a decrease in double positive CD4+CD8+ T cells. These changes were inhibited by concomitant treatment with GH and the GH receptor (GHR) antagonist pegvisomant. However, GH treatment also induced a significant decrease in FTOC Gh, Ghr and Igf1 expression. Conclusion: These data show that the thymotropic properties of the somatotrope GH/IGF-1 axis involve an interaction between exogenous GH and GHR expressed by TEC. Since thymic IGF-1 is not increased by GH treatment, the effects of GH upon T cell differentiation could implicate a different local growth factor or cytokine.
This content is only available via PDF.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental